Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-17

Clinical Trial Update: Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the effects of finasteride on serum prostate-specific antigen in androgenetic alopecia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FINASTERIDE (FINASTERIDE)

Snippet

Sponsor: Organon and Co | Conditions: Androgenetic Alopecia | Phase 3 | Status: COMPLETED